CT引导下经皮微波消融肺结节:安全性、疗效与并发症研究进展

doi:10.19983/j.issn.2096-8493.20250147

结核与肺部疾病杂志 ›› 2026, Vol. 7 ›› Issue (2): 262-267.doi: 10.19983/j.issn.2096-8493.20250147

• 综述 • 上一篇

CT引导下经皮微波消融肺结节:安全性、疗效与并发症研究进展

高倩¹^,², 陆霓虹³(), 杨艳²

¹ 云南省大理大学公共卫生学院, 大理 671003
² 昆明市第三人民医院呼吸与危重症医学科, 昆明 650041
³ 昆明医科大学第二附属医院呼吸与危重症医学科, 昆明 650000

收稿日期:2025-09-20 出版日期:2026-04-20 发布日期:2026-04-13
通信作者: 陆霓虹 E-mail:602157606@qq.com
基金资助:
云南省科技厅科技计划项目(202303AC100026);云南省教育厅科学研究基金项目(2025J0798);国家自然科学基金地区科学基金项目(82460016)

Percutaneous microwave ablation of pulmonary nodules under CT guidance: study progress of safety, effectiveness and complication

Gao Qian¹^,², Lu Nihong³(), Yang Yan²

¹ Public Health College of Dali University, Yunnan Province, Dali 671003, China
² The Department of Respiratory and Critical Care Medicine of the Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China
³ The Department of Respiratory and Critical Care Medicine of The Third People’s Hospital of Kunming City, Yunnan Province, Kunming 650041, China

Received:2025-09-20 Online:2026-04-20 Published:2026-04-13
Contact: Lu Nihong E-mail:602157606@qq.com
Supported by:
Science and Technology Plan Project of Yunnan Provincial Department of Science and Technology(202303AC100026);Scientific Research Fund Project of Yunnan Provincial Department of Education(2025J0798);National Natural Science Foundation of China Regional Science Foundation Project(82460016)

摘要/Abstract

摘要：

随着计算机断层扫描筛查的普及,肺结节的检出率显著增加。目前,针对肺结节的治疗以传统外科手术为主,虽然效果确切,但创伤大、恢复慢,部分患者因心肺功能差而无法耐受。近年来,CT引导下经皮微波消融术(percutaneous microwave ablation,PMWA)作为一种微创治疗技术,在肺结节局部治疗中显示出良好的应用前景。作者旨在探讨PMWA的技术原理、安全性特征、临床疗效及并发症管理策略,并提出该技术面临的挑战和未来发展方向,为临床医护人员综合治疗肺结节提供更全面的理论依据和实践指导。

关键词: 微波消融术, 结节病,肺, 安全性, 疗效, 手术后并发症, 体层摄影扫描仪,X线计算机

Abstract:

With the popularization of computed tomography (CT) screening, the detection rate of pulmonary nodules has significantly increased. At present, treatment for pulmonary nodules mainly relies on traditional surgical operation, for which although its effectiveness is definite, it goes with large trauma and slow recovery, thus some patients cannot tolerate it due to poor heart and lung functions. In recent years, CT-guided percutaneous microwave ablation (PMWA), as a minimally invasive treatment technique, has shown promising application prospects in the local treatment of pulmonary nodules. The authors aim to explore the technical principles, safety features, clinical effectiveness and complication management strategies of PMWA, and to present the challenges and future development directions faced by this technology, providing more comprehensive theoretical basis and practical guidance for clinical medical staff to provide comprehensive treatment of pulmonary nodules.

Key words: Microwave ablation, Sarcoidosis, pulmonary, Safety, Efficacy, Postoperative complications, Tomography scanner, X-ray computer

中图分类号:

R734.2

高倩, 陆霓虹, 杨艳. CT引导下经皮微波消融肺结节:安全性、疗效与并发症研究进展[J]. 结核与肺部疾病杂志, 2026, 7(2): 262-267. doi: 10.19983/j.issn.2096-8493.20250147

Gao Qian, Lu Nihong, Yang Yan. Percutaneous microwave ablation of pulmonary nodules under CT guidance: study progress of safety, effectiveness and complication[J]. Journal of Tuberculosis and Lung Disease, 2026, 7(2): 262-267. doi: 10.19983/j.issn.2096-8493.20250147

图/表 3

参考文献 42

[1]	中华医学会呼吸病学分会, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2024年版). 中华结核和呼吸杂志, 2024, 47(8):716-729. doi:10.3760/cma.j.cn112147-20231109-00300.
[2]	张洁, 李杰, 刘澄英. 良、恶性肺结节临床特征及影响因素分析. 江苏医药, 2024, 50(12): 1242-1245. doi:10.19460/j.cnki.0253-3685.2024.12.012.
[3]	Zhang Q, Wu X, Yang H, et al. Advances in the Treatment of Pulmonary Nodules. Respiration, 2024, 103(3):134-145. doi:10.1159/000535824.
[4]	Izzo F, Granata V, Grassi R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors:An Update. Oncologist, 2019, 24(10):e990-e1005. doi:10.1634/theoncologist.2018-0337.
[5]	Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol, 2010, 21(8): S192-S203. doi:10.1016/j.jvir.2010.04.007.
[6]	Iezzi R, Cioni R, Basile D, et al. Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study). Eur Radiol, 2021, 31(4): 2173-2182. doi:10.1007/s00330-020-07299-2.
[7]	Yu J, Cheng ZG, Han ZY, et al. Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience. Liver Cancer, 2022, 11(4): 341-353. doi:10.1159/000522134. pmid: 35978603
[8]	Aarts BM, Gomez FM, Lopez-yurda M, et al. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Eur Radiol, 2023, 33(2): 1040-1049. doi:10.1007/s00330-022-09110-w.
[9]	Dong F, Wu Y, Li W, et al. Advancements in microwave ablation for tumor treatment and future directions. iScience. 2025, 28(4):112175. doi:10.1016/j.isci.2025.112175.
[10]	赵玉彪, 张洪杰, 张覃, 等. CT引导下微波消融肺结节联合术中穿刺活检的临床应用及预防出血措施分析. 影像研究与医学应用, 2024, 8(7): 177-179. doi:10.3969/j.issn.2096-3807.2024.07.058.
[11]	Ward RC, Healey TT, Dupuy DE. Microwave ablation devices for interventional oncology. Expert Rev Med Devices. 2013, 10(2):225-238. doi:10.1586/erd.12.77. pmid: 23480091
[12]	Ye X, Fan W, Wang H, et al. Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J Cancer Res Ther, 2018, 14(4): 730-744. doi:10.4103/jcrt.JCRT_221_18. pmid: 29970646
[13]	中国临床肿瘤学会(CSCO)肿瘤消融治疗专家委员会, 中国医师协会肿瘤消融治疗技术专家组, 中国抗癌协会肿瘤消融治疗专业委员会, 等. 影像引导下热消融治疗原发性和转移性肺部肿瘤临床实践指南(2021年版). 中华内科杂志, 2021, 60(12):1088-1105. doi:10.3760/cma.j.cn112138-20210814-00554.
[14]	叶欣, 王俊, 危志刚, 等. 热消融治疗肺部亚实性结节专家共识(2021年版). 中国肺癌杂志, 2021, 24(5): 305-322. doi:10.3779/j.issn.1009-3419.2021.101.14.
[15]	辛少伟, 杨阳, 高峰, 等. 38例肺癌的CT引导下微波消融安全性及初步疗效临床总结. 现代生物医学进展, 2024, 24(23): 4444-4448. doi:10.13241/j.cnki.pmb.2024.23.009.
[16]	刘豪, 杨云龙. CT引导经皮微波消融治疗肺结节的安全性及短期疗效评价. 中国临床研究, 2022, 35(7): 982-985. doi:10.13429/j.cnki.cjcr.2022.07.019.
[17]	Yang X, Jin Y, Lin Z, et al. Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study. J Cancer Res Ther, 2023, 19(4): 1001-1010. doi:10.4103/jcrt.jcrt_1436_23. pmid: 37675729
[18]	Reisenauer JS, Eiken PW, Callstrom MR, et al. A prospective trial of CT-guided percutaneous microwave ablation for lung tumors. J Thorac Dis, 2022, 14(4):939-951. doi:10.21037/jtd-21-1636. pmid: 35572874
[19]	Li B, Gao S, Mao J, et al. A retrospective study of microwave ablation and thoracoscopic surgery for multiple primary lung cancer: a propensity score matching analysis. Front Surg, 2025, 12: 1547048. doi:10.3389/fsurg.2025.1547048.
[20]	荣振华, 焦言, 纪永琪, 等. 肺癌合并重度慢性阻塞性肺疾病的微波消融治疗临床分析. 影像研究与医学应用, 2020, 4(24): 21-22. doi:10.3969/j.issn.2096-3807.2020.24.011.
[21]	Cui SP, Zhao Q, Wang J, et al. Exploring the impact of variable power outputs on the efficacy and safety during microwave ablation for lung carcinoma: a real-world study. J Thorac Dis, 2024, 16(8): 5031-5041. doi:10.21037/jtd-24-557.
[22]	张树亮, 张孝勇, 林玮, 等. 基于胸外科临床实践的穿刺导航机器人辅助肺结节消融技术进展. 机器人外科学杂志(中英文), 2025, 6(7): 1080-1089. doi:10.12180/j.issn.2096-7721.2025.07.002.
[23]	Zhang L, Zhang M, Wang J, et al. Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood. Front Immunol, 2022, 13: 1069192. doi:10.3389/fimmu.2022.1069192.
[24]	Cao B, Liu M, Wang L, et al. Remodelling of tumour microen-vironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer. Nat Commun, 2022, 13(1):6203. doi:10.1038/s41467-022-33968-5.
[25]	刘宝东, 支修益. 影像引导下热消融治疗肺部肿瘤的局部疗效评价. 中国医学前沿杂志(电子版), 2015, (2):11-14. doi:10.3969/j.issn.1674-7372.2015.02.004.
[26]	Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5): 989-997. doi:10.1007/s00270-010-0048-z. pmid: 21127867
[27]	Abtin F, De Baere T, Dupuy DE, et al. Updates on Current Role and Practice of Lung Ablation. J Thorac Imaging, 2019, 34(4): 266-277. doi:10.1097/RTI.0000000000000417.
[28]	Geevarghese R, Alexander ES, Elsakkaa A, et al. Outcomes following microwave ablation of 669 primary and metastatic lung malignancies. Eur Radiol, 2026, 36(3):2295-2304. doi:10.1007/s00330-025-11973-8.
[29]	李惠, 叶欣. 肺癌微波消融治疗研究十年现状. 实用肿瘤杂志, 2024, 39(4):291-298. doi:10.13267/j.cnki.syzlzz.2024.045.
[30]	Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol, 2021, 31(7): 5421-5433. doi:10.1007/s00330-020-07634-7. pmid: 33449192
[31]	Wei Z, Zhang K, Ye X, et al. Computed tomography-guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer. Skeletal Radiol, 2015, 44(10): 1485-1490. doi:10.1007/s00256-015-2195-4. pmid: 26112311
[32]	Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol, 2014, 110(6): 758-763. doi:10.1002/jso.23701. pmid: 24965604
[33]	张达毅, 蔡跃东, 王晓聪. 肺结节患者微波消融术治疗效果的影响因素分析. 福建医药杂志, 2025, 47(1): 43-46. doi:10.20148/j.fmj.2025.01.013.
[34]	沈旭, 沈诚, 肖丛佳, 等. 多发肺结节消融治疗的研究进展. 中国胸心血管外科临床杂志, 2025, 32(3): 401-405. doi:10.7507/1007-4848.202306025.
[35]	Zhang HF, Liao MY, Zhu DY, et al. Lung radiodensity along the needle passage is a quantitative predictor of pneumothorax after CT-guided percutaneous core needle biopsy. Clin Radiol, 2018, 73(3):319.e1-e319.e7. doi:10.1016/j.crad.2017.10.010.
[36]	王丽娜, 刘建, 史宏璐, 等. CT引导下经皮肺微波消融术中疼痛的风险评估. 医学影像学杂志, 2025, 35(2): 55-59. doi:10.20258/j.cnki.1006-9011.2025.02.013.
[37]	张亚楠, 吴献华, 仲楼, 等. CT引导下肺癌微波消融后空洞形成的相关研究. 实用放射学杂志, 2019, 35(1): 106-109. doi:10.3969/j.issn.1002-1671.2019.01.027.
[38]	Xu C, Wang Y, Li Y, et al. A major complication of microwave ablation in a patient with surgically treated ground-glass opacity. J Cancer Res Ther, 2025, 21(2): 518-521. doi:10.4103/jcrt.jcrt_2479_24. pmid: 40317160
[39]	Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6): 1765-1774. doi:10.1245/s10434-008-9848-7. pmid: 18368456
[40]	刘强. 经皮CT引导下肺结节微波消融术后并发症及其危险因素的研究. 南宁:广西医科大学, 2022. doi:10.27038/d.cnki.ggxyu.2022.000077.
[41]	Wu CC, Maher MM, Shepard JA. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. AJR Am J Roentgenol, 2011, 196(6): W678-W682. doi:10.2214/AJR.10.4659.
[42]	中国抗癌协会肿瘤介入学专业委员会, 中国抗癌协会肿瘤介入学专业委员会胸部肿瘤诊疗专家委员会. 胸部肿瘤经皮穿刺活检中国专家共识(2020版). 中华医学杂志, 2021, 101(3):185-198. doi:10.3760/cma.j.cn112137-20200907-02576.

效果	CT (肿瘤大小)	CT (肿瘤密度)	PET或 PET-CT
完全消融	缩小或不变	无强化区	无代谢区
不完全消融	不变或增大	强化区无变化	高代谢区无变化
局部进展	增大10mm	新出现或强化区增大	新出现或高代谢区增大

CT引导下经皮微波消融肺结节:安全性、疗效与并发症研究进展

Percutaneous microwave ablation of pulmonary nodules under CT guidance: study progress of safety, effectiveness and complication

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 42

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王红芳. 盐酸氨溴索与抗生素在慢性支气管炎治疗中的效果研究[J]. 结核与肺部疾病杂志, 2025, 6(S1): 21-23.
[2]	周仕奇. 无创机械通气在重症创伤并发急性呼吸衰竭中的应用效果[J]. 结核与肺部疾病杂志, 2025, 6(S1): 52-54.
[3]	张潇文. 沐舒坦加酚妥拉明注射液治疗小儿支气管肺炎的临床价值[J]. 结核与肺部疾病杂志, 2025, 6(S1): 55-57.
[4]	田晓梅, 何小雪, 雷娟, 王晓炜, 古建军. 2019—2023年宁夏回族自治区病原学阳性肺结核治疗效果及影响因素分析[J]. 结核与肺部疾病杂志, 2025, 6(6): 703-709.
[5]	郭帅, 汪容娟. 肺心病合并上消化道出血的临床治疗效果分析[J]. 结核与肺部疾病杂志, 2024, 5(S): 18-20.
[6]	吴朝红. 女性生殖器结核不孕患者腹腔镜检查特点及临床疗效评估价值[J]. 结核与肺部疾病杂志, 2024, 5(S): 35-37.
[7]	王继州. 经皮肾镜取石术对肾结石合并轻度肺功能障碍患者的疗效及安全性分析[J]. 结核与肺部疾病杂志, 2024, 5(S): 64-66.
[8]	董文竹, 唐静, 王聃, 徐李兵, 王艳, 肖贵宝. 母牛分枝杆菌菌苗联合常规抗结核治疗方案治疗HIV并发肺结核患者的临床效果分析[J]. 结核与肺部疾病杂志, 2024, 5(S): 67-69.
[9]	夏莎莎. 急诊护理干预在慢性阻塞性肺疾病患者中的急诊治疗效果[J]. 结核与肺部疾病杂志, 2024, 5(S): 108-110.
[10]	张哲男, 姜南阳, 王威, 姜连炬, 刘玉琴. 两种不同手术方式对颈部淋巴结结核患者的疗效分析[J]. 结核与肺部疾病杂志, 2021, 2(1): 26-30.
[11]	辛五群, 陈晓, 汤金星, 徐高俊, 周振强, 何苡. 肺癌经胸腔镜切除术后继发持续性咳嗽的影响因素分析[J]. 结核与肺部疾病杂志, 2021, 2(1): 31-37.
[12]	王颖, 蔡春葵, 许岩, 孙诗学, 李刚, 顾晓峰, 于洋. 利奈唑胺治疗广泛耐药肺结核疗效分析[J]. 结核与肺部疾病杂志, 2020, 1(2): 136-139.
[13]	肖阳宝, 罗林紫, 卢志斌, 冯丹, 白丽琼, 罗莉. 超声引导下淋巴结穿刺注射给药联合冷冻治疗破溃期淋巴结瘘型气管支气管结核的价值[J]. 结核与肺部疾病杂志, 2020, 1(2): 149-153.
[14]	蒋玲, 罗廷茹, 周小琦, 唐娜, 蒙昌平, 钱春芳. 含利奈唑胺化疗方案治疗重症结核性脑膜炎的效果评价[J]. 结核病与肺部健康杂志, 2020, 9(1): 44-48.
[15]	刘思梅, 奚修凤, 李冰. 呼吸训练干预对慢性阻塞性肺疾病患者呼吸功能和生活质量的影响[J]. 结核与肺部疾病杂志, 2020, 1(1): 34-38.